GB600337A - New pyrimidine compounds - Google Patents

New pyrimidine compounds

Info

Publication number
GB600337A
GB600337A GB2350345A GB2350345A GB600337A GB 600337 A GB600337 A GB 600337A GB 2350345 A GB2350345 A GB 2350345A GB 2350345 A GB2350345 A GB 2350345A GB 600337 A GB600337 A GB 600337A
Authority
GB
United Kingdom
Prior art keywords
group
amino
nrr1
methylpyrimidine
diamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2350345A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BARBARA JEAN LOVELL
Imperial Chemical Industries Ltd
Original Assignee
BARBARA JEAN LOVELL
Imperial Chemical Industries Ltd
Filing date
Publication date
Application filed by BARBARA JEAN LOVELL, Imperial Chemical Industries Ltd filed Critical BARBARA JEAN LOVELL
Publication of GB600337A publication Critical patent/GB600337A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/38One sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Pyrimidine compounds, useful as chemotherapeutic agents or as intermediates therefor, and of the general formula <FORM:0600337/IV(b)/1> wherein X represents hydrogen or a hydrocarbon radical and Y hydrogen or a neutral substituent, or X and Y together form an alkylene chain, R11 represents hydrogen or an alkyl or substituted alkyl (e.g. alkoxyalkyl or dialkylaminoalkyl) group, A represents an aliphatic or alicyclic linking group, which may be substituted by hydroxy, alkoxy or dialkylaminoalkyl groups, and, when an aliphatic chain, may be interrupted by oxygen, sulphur or nitrogen atoms, and NRR1 represents an amino or substituted amino group such as acylamino, alkylamino, dialkylamino or piperidino or other strongly basic nitrogen-containing heterocyclic group, are manufactured by the interaction of a diamine NHN11-A-NRR1 with an appropriate pyrimidine derivative containing in the 2-position a labile substituent such as a halogen atom or a hydrocarbon radical attached by an ether or thioether linkage, e.g. an alkoxy, aryloxy or alkylmercapto group. The reaction may be effected by heating the reagents together, optionally in the presence of a solvent or diluent. One or other of the reagents may be employed in the form of a salt, e.g. hydrochloride or acetate, and if desired an acid-bonding agent, e.g. sodium hydroxide, may be present. When R1 represents hydrogen, it is usually necessary to employ an acylated diamine NHN11-A-NRAc and subsequently to hydrolyse the acylamino group. Another modification consists in introducing the substituent -NR11-A-NRN1 in stages by reacting the 4 - aminopyrimidine derivative carrying a labile substituent with an amino compound NHN11-A1-B, where A1 represents the whole or a part of the linking group A, and B represents a reactive group (e.g. a hydroxy group or a derivative thereof which is, or is readily convertible to, a reactive ester thereof, such as a halide), which group is then converted directly or indirectly by methods involving the step of reaction with ammonia or a compound containing an amino group into the amino group NRR1 or a group A11-NRN1 such that A1 and A11 together constitute the group A, e.g. by reaction with an amine NHRR1 or a substituted amine NH2-A111-NRR1, HO-A111-NRN1 or HS-A111-NRR1 (or an alkali metal derivative of the hydroxy or mercapto compound) such that A1-NH-A111, A1-O-A111 or A1-S-A111 constitutes the group A. A terminal amino group, when unsubstituted, may, if desired, be modified, e.g. by alkylation, conversion to a heterocyclic group such as piperidino, or reaction with a halogen-substituted amine Hal-A111-NRR1 so as to extend the linking group A to A-NH-A111. In examples: (1) 4-amino-2-methylmercapto-5 : 6-dimethylpyrimidine is heated in an autoclave with g -diethylaminopropylamine to produce 4-amino-2-g -diethylaminopropylamino - 5 : 6 - dimethylpyrimidine; (2) the diamine in (1) is replaced by b -diethylaminoethylamine; (3) 2 - chloro - 4 - amino - 6 - methyl - pyrimidine and b -diethylaminoethylamine are refluxed together to form 2-b -diethylaminoethylamino-4-amino-6-methylpyrimidine; (4) the diamine in (3) is replaced by d -diethylamino-a -methylbutylamine; (5) by g -diethylaminopropylamine; and (6) by g -dibutylaminopropylamine; (7) 4 - amino - 2 - methylmercapto - 6 - methylpyrimidine is heated in an autoclave with g -dimethylaminopropylamine to yield 4 - amino - 2 - g - dimethylaminopropylamino-6-methylpyrimidine. Specifications 605,784 and 606,181 are referred to. 2-Ethylmercapto-4-amino-5-methylpyrimidine and 2 - methylmercapto - 4 - amino - 5 : 6 - dimethyl - pyrimidine are obtainable by the action of alcoholic ammonia on the corresponding 4-chloro compounds, which in turn may be made by chlorination of the 4-hydroxy compounds.
GB2350345A 1945-11-12 New pyrimidine compounds Expired GB600337A (en)

Publications (1)

Publication Number Publication Date
GB600337A true GB600337A (en) 1948-04-06

Family

ID=1737711

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2350345A Expired GB600337A (en) 1945-11-12 New pyrimidine compounds

Country Status (1)

Country Link
GB (1) GB600337A (en)

Similar Documents

Publication Publication Date Title
GB1212273A (en) 0,2,4-triazine-5-ones
LEONARD et al. PREPARATION OF 4-MERCAPTO AND 4-AMINO QUINAZOLINES1
GB1027614A (en) Water-soluble reactive dyes
GB583815A (en) New pyrimidine compounds
GB600337A (en) New pyrimidine compounds
GB1045534A (en) New 1-benzyl-5,6-dialkoxy benzimidazoles and a process for their manufacture
GB866843A (en) Sulphonamidopyrimidines
GB677342A (en) New pyrimidine derivatives and their use in the manufacture of pteridin derivatives
GB823191A (en) New phenthiazine derivatives and processes for their preparation
GB1123762A (en) Improved process for the production of 5-cyano-uracil compounds and new intermediate products that can be formed thereby
GB590706A (en) New pyrimidine compounds
GB593499A (en) New pyrimidine compounds
GB587548A (en) New pyrimidine compounds
US3758472A (en) Preparation of-2-alkoxy-4-hydroxypyrimidines
GB948175A (en) Process for the production of 2, 4-diamino-6-trichloromethyl-úË-triazines
GB597969A (en) New pyrimidine compounds
GB592928A (en) New pyrimidine compounds
US2561658A (en) Mergapto folic acid and process of
GB1064570A (en) Method for producing 2-mercapto-4,6-bis(amino)1,3,5-triazine derivatives
GB1023218A (en) Substituted pyrido [2,3-e]-triazine 1-oxides
GB776118A (en) New heterocyclic compounds and their production
US2443304A (en) Halogenopyrimidine derivatives
GB845378A (en) New pyrimidines
GB839784A (en) Phenothiazine derivatives
GB793088A (en) Acridan derivatives